GlassScriptPhysician profile
Michelle Silva
NPI 1306377403
$1,849.28
in general payments reported to CMS, 2019-2025
21 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $438 · 2022: $389 · 2023: $456 · 2024: $378 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,022.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $321.26 | 2021-2024 | Lo Loestrin Fe |
| Pacira Pharmaceuticals Incorporated | $272.99 | 2021-2024 | Exparel |
| Mayne Pharma Commercial LLC | $154.56 | 2022-2025 | |
| Davol INC. | $140.16 | 2023 | Arista Ah Flexitip |
| Astellas Pharma US INC | $112.00 | 2024 | Veozah |
| Hologic Sales and Service, LLC | $111.55 | 2024-2025 | Aptima, Thinprep 2000 Processor, Fetal Fibronectin Enzyme Immunoassay |
| Genentech USA, INC. | $105.92 | 2021 | |
| Daiichi Sankyo INC. | $87.80 | 2021-2025 | Injectafer |
| Organon LLC | $83.65 | 2023-2025 | Nexplanon, Jada System |
| Coopersurgical, INC. | $82.21 | 2023-2025 | Mara Console, Paragard T 380a |
| Myriad Women'S Health, INC. | $64.79 | 2023 | Myrisk |
| Therapeuticsmd, INC. | $59.78 | 2021-2022 | |
| Millicent US INC | $47.35 | 2024-2025 | Intrarosa, Femlyv |
| Mylan Pharmaceuticals INC. | $40.49 | 2022 | |
| Shield Therapeutics INC | $35.58 | 2023-2024 | Accrufer |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $32.27 | 2021-2022 | |
| Mycovia Pharmaceuticals, INC. | $28.23 | 2023 | Vivjoa |
| Sage Therapeutics, LLC | $20.42 | 2023 | |
| Gynesonics, INC. | $19.40 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Glaxosmithkline, LLC. | $15.03 | 2024 | Bexsero |
| Agile Therapeutics, INC. | $13.84 | 2023 | Twirla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.